SSBP2 Inhibitors

Chemical inhibitors of SSBP2 can exert their inhibitory effects through interference with DNA repair and replication processes. Mitoxantrone, etoposide, teniposide, amsacrine, doxorubicin, daunorubicin, merbarone, and ICRF-193 are all inhibitors of topoisomerase II, an enzyme essential for DNA replication and repair, where SSBP2 also plays a role. The inhibition of topoisomerase II by these agents can lead to the accumulation of DNA breaks and the disruption of the DNA repair machinery. Since SSBP2 is involved in DNA repair, its function is inherently compromised when the DNA structure is destabilized or when the repair process is arrested. For instance, doxorubicin and daunorubicin intercalate into DNA, causing additional structural impediments to DNA processing, which further inhibits the function of SSBP2 in maintaining genomic integrity. Merbarone and ICRF-193, on the other hand, bind to the topoisomerase II enzyme, preventing its normal action without causing DNA cleavage, which can lead to a different kind of functional inhibition of SSBP2 through the prevention of proper DNA replication and repair.

Further, chemicals like ellipticine and pixantrone are also DNA intercalating agents that inhibit topoisomerase II, leading to a disruption of the DNA replication and repair pathways where SSBP2 is involved. The stabilization of the DNA-topoisomerase II complex by these inhibitors can prevent the proper religation of DNA strands, thereby hindering the DNA repair processes and the role of SSBP2 within them. Idarubicin, with its intercalating properties and topoisomerase II inhibitory activity, promotes a similar inhibitory effect on SSBP2 by destabilizing the DNA and disrupting the normal function of DNA repair complexes. Exatecan, although primarily a topoisomerase I inhibitor, can indirectly affect SSBP2 by disrupting the fidelity of DNA replication, which necessitates the involvement of DNA repair proteins including SSBP2, leading to an overall inhibition of its activity.